NU SKIN ENTERPRISES, INC. (NUS) — SEC Filings

Latest SEC filings for NU SKIN ENTERPRISES, INC. (NUS), explained in plain English.

Sentiment Overview: 1 bullish, 1 bearish, 33 neutral, 3 mixed

Recent Filings (38)

• Nu Skin Swings to Profit on Mavely Sale, Despite Revenue Dip — 10-Q · 2025-11-07T00:00:00.000Z [mixed] Risk: medium
  NU SKIN ENTERPRISES, INC. (NUS) reported a significant turnaround in net income for the nine months ended September 30, 2025, reaching $145.7 million, a substan
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2025-11-06T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on November 6, 2025, reporting on its results of operations and financial condition. The filing also includes financial s
• Nu Skin's Q2 Revenue, Net Income Plunge Amid Market Headwinds — 10-Q · 2025-08-08T00:00:00.000Z [bearish] Risk: high
  NU SKIN ENTERPRISES, INC. reported a challenging second quarter and first half of 2025. For the three months ended June 30, 2025, revenue decreased to $440.5 mi
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2025-08-07T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing also includes financial sta
• Nu Skin Enterprises Files 8-K on Director/Officer Changes — 8-K · 2025-05-30T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed an 8-K on May 30, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compens
• Nu Skin Enterprises Q1 2025 10-Q Filed — 10-Q · 2025-05-09T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. A significant n
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
• Nu Skin Enterprises Files 2025 Proxy Statement — DEF 14A · 2025-04-04T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed its DEF 14A proxy statement on April 4, 2025, for the fiscal year ending December 31, 2024. The filing details executive compens
• Nu Skin Enterprises Announces Executive and Board Changes — 8-K · 2025-03-06T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. announced on March 5, 2025, a series of executive and board changes. These include the departure of certain officers and directors, th
• Nu Skin Enterprises Files 2024 10-K — 10-K · 2025-02-14T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed its 2024 10-K on February 14, 2025, reporting on its fiscal year ending December 31, 2024. The filing details the company's fina
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2025-02-13T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on February 13, 2025, reporting on its results of operations and financial condition, and including financial statements
• Nu Skin Enterprises Files 8-K on Operations and Financials — 8-K · 2025-01-13T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition, and including financial statements a
• Nu Skin Enterprises Completes Acquisition — 8-K · 2025-01-03T00:00:00.000Z [neutral] Risk: medium
  On January 2, 2025, Nu Skin Enterprises, Inc. announced the completion of its acquisition of a business, entering into a material definitive agreement. The fili
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• Nu Skin Enterprises Files Q3 2024 10-Q — 10-Q · 2024-11-08T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the thir
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2024-11-07T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statem
• SC 13G/A Filing — SC 13G/A · 2024-11-06T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-04T00:00:00.000Z [neutral]
• Nu Skin Enterprises Changes Fiscal Year End — 8-K · 2024-11-01T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on November 1, 2024, reporting a change in its fiscal year end from December 31 to October 31. This change is effective a
• SC 13G/A Filing — SC 13G/A · 2024-10-18T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-10-07T00:00:00.000Z [neutral]
• Nu Skin Enterprises Board Shake-up — 8-K · 2024-09-12T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. announced on September 10, 2024, the departure of two directors, R. Brent Beesley and Steven J. Lund. The company also announced the e
• Nu Skin Enterprises Files 10-Q for Q2 2024 — 10-Q · 2024-08-09T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial fi
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2024-08-08T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
• Nu Skin Appoints New CFO, Grants Stock and Bonus — 8-K · 2024-06-06T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. announced on June 5, 2024, the appointment of Jason Wight as Chief Financial Officer, effective June 10, 2024. He will receive an annu
• Nu Skin Enterprises Files Q1 2024 10-Q — 10-Q · 2024-05-09T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first qu
• Nu Skin Enterprises Files 8-K on Financials — 8-K · 2024-05-08T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed an 8-K on May 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
• Nu Skin Enterprises Files 2024 Proxy Statement — DEF 14A · 2024-04-12T00:00:00.000Z [neutral] Risk: low
  Nu Skin Enterprises, Inc. filed its definitive proxy statement on April 12, 2024, for its annual meeting on June 5, 2024. The filing details executive compensat
• Nu Skin Appoints New CFO, Hetherington — 8-K · 2024-03-18T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. announced on March 15, 2024, the appointment of Jason Hetherington as Chief Financial Officer, effective March 18, 2024. He will recei
• Nu Skin's 10-K Details Variable Rate Debt and Payment Schedule — 10-K · 2024-02-15T00:00:00.000Z [mixed] Risk: medium
  NU SKIN ENTERPRISES, INC. filed its 10-K on February 15, 2024, for the fiscal year ending December 31, 2023. The filing details debt obligations, including a va
• Nu Skin Files 8-K on Financials & Officer Changes — 8-K · 2024-02-14T00:00:00.000Z [neutral] Risk: medium
  Nu Skin Enterprises, Inc. filed an 8-K on February 14, 2024, reporting events that occurred on February 9, 2024. The filing indicates updates regarding the comp
• Vanguard Trims Nu Skin Stake to 8.0% as of Dec 29, 2023 — SC 13G/A · 2024-02-13T00:00:00.000Z [mixed] Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Nu Skin Enterprises, Inc. Class A Commo
• Invesco Discloses 5.0% Passive Stake in Nu Skin Enterprises — SC 13G · 2024-02-09T00:00:00.000Z [bullish] Risk: low
  Invesco Ltd., a major investment advisor, reported owning 5.0% of Nu Skin Enterprises Inc.'s common stock as of December 29, 2023. This filing, an SC 13G, indic
• Wellington Management Discloses 9.99% Stake in Nu Skin — SC 13G/A · 2024-02-08T00:00:00.000Z [neutral] Risk: low
  Wellington Management Group LLP, a major investment firm, filed an amended Schedule 13G/A on February 8, 2024, indicating a change in their ownership of Nu Skin
• NU SKIN: No Charter/Bylaw Amendments or Fiscal Year Change — 8-K · 2024-02-06T00:00:00.000Z [neutral]
  On February 5, 2024, NU SKIN ENTERPRISES, INC. filed an 8-K to report no changes to its Articles of Incorporation or Bylaws, nor any change in its fiscal year.
• State Street Corp Amends Nu Skin Stake, Maintains Passive Position — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  State Street Corp, a major institutional investor, filed an amended Schedule 13G/A on January 25, 2024, indicating its ownership of Nu Skin Enterprises Inc. com
• BlackRock Amends Nu Skin Stake, Signals Passive Investment Update — SC 13G/A · 2024-01-22T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in their ownership of NU SKIN ENTERPRISES INC Class A Common Stock as of Decem
• Nu Skin Files 8-K Current Report on Operations & Financials — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  Nu Skin Enterprises, Inc. filed an 8-K on January 8, 2024, indicating it is making a filing under Section 13 or 15(d) of the Securities Exchange Act of 1934. Th